T2D devices – What GPs need to know about CGM

   Rated 0 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

In this episode:

  • Patients on medications that have a low incidence of hypoglycaemia with T2DM do not need finger-prick blood glucose testing. GPs will rely on HbA1C to guide management. However, its use in Sick Days management is still important
  • When to test for ketones in T2DM? No real indication in T2DM except in insulin deficiency eg. LADA
  • The widespread use of SGLT2 inhibitors had increased the incidence of ketoacidosis often triggered by an intercurrent illness. Check blood ketone levels or at least urinary ketones for all patients on SGLT2 inhibitors who have an intercurrent illness or report feeling unwell with nausea, abdominal pain
  • Continuous glucose monitoring (CGM) can give patients a good understanding of what impact various foods and types of exercise have on their blood glucose levels

 

Host: Dr David Lim, GP and Medical Educator

Total time: 36 mins

Guest: A/Prof Gary Kilov, General Practitioner

 

Last Updated: 25 Oct, 2021

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Fiona Chan

Dr Fiona Chan

Multiple Sclerosis vs Antibody Disease – What GPs Need to Know

Prof Andrew Sindone & Dr Ted Wu

Prof Andrew Sindone & Dr Ted Wu

Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs

Prof Rod Baber

Prof Rod Baber

Menopause and MHT: Maximising Benefits & Minimising Risks

Dr Shannon Thomas

Dr Shannon Thomas

Peripheral Arterial Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Gary Kilov

expert

A/Prof Gary Kilov

General Practitioner; Founding Member, The RACGP Diabetes Specific Interest Group; Co-founder, The Primary Care Diabetes Society of Australia

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease